Literature DB >> 23288506

Ocular complications associated with systemic medications used in allergy/immunology practice.

Avinash Gurbaxani1, Clare L Fraser, Simon E Skalicky, Peter McCluskey.   

Abstract

The repertoire of treatment options available to allergists and immunologists is ever increasing and with this comes the increased potential for these treatments to cause adverse ocular side effects. Corticosteroids remain the first line of treatment for most immunological disorders and physicians should be alerted to their extensive ocular morbidity profile. Patients requiring longer-term therapy may often receive immune modulators or newer biologic agents. While effective, these medications may have additional ocular side effects; as newer agents are more frequently used, some of these may not be previously documented. A number of patients will seek alternative or herbal remedies for these long-term conditions, often unknown to the treating physician; these too can cause harmful ocular morbidity. We review the latest information about the potential ocular side effects that may be encountered in treating patients with medications used in allergic and immunological disorders.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23288506     DOI: 10.1007/s11882-012-0333-9

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  51 in total

1.  Glaucoma secondary to topical use of steroid cream.

Authors:  G W thoe Schwartzenberg; Y M Buys
Journal:  Can J Ophthalmol       Date:  1999-06       Impact factor: 1.882

2.  Retrobulbar haemorrhage associated with chronic Gingko biloba ingestion.

Authors:  K C S Fong; P E Kinnear
Journal:  Postgrad Med J       Date:  2003-09       Impact factor: 2.401

3.  Retinopathy following chloroquine therapy.

Authors:  H E HOBBS; A SORSBY; A FREEDMAN
Journal:  Lancet       Date:  1959-10-03       Impact factor: 79.321

4.  Tuberculosis in a nine-year-old girl treated with infliximab for systemic juvenile idiopathic arthritis.

Authors:  W Armbrust; S S M Kamphuis; T W F Wolfs; T J W Fiselier; P G Nikkels; W Kuis; N M Wulffraat
Journal:  Rheumatology (Oxford)       Date:  2004-04       Impact factor: 7.580

Review 5.  Dose-response relationship of inhaled corticosteroids and cataracts: a systematic review and meta-analysis.

Authors:  Mark Weatherall; Jennifer Clay; Kate James; Kyle Perrin; Philippa Shirtcliffe; Richard Beasley
Journal:  Respirology       Date:  2009-09       Impact factor: 6.424

6.  An evaluation of the ocular drying effects of 2 systemic antihistamines: loratadine and cetirizine hydrochloride.

Authors:  George W Ousler; Katrina A Wilcox; Gaurav Gupta; Mark B Abelson
Journal:  Ann Allergy Asthma Immunol       Date:  2004-11       Impact factor: 6.347

Review 7.  Non-hormonal systemic medications and dry eye.

Authors:  John Wong; Wanwen Lan; Li Ming Ong; Louis Tong
Journal:  Ocul Surf       Date:  2011-10       Impact factor: 5.033

Review 8.  Uses and complications of isotretinoin therapy.

Authors:  C N Ellis; K J Krach
Journal:  J Am Acad Dermatol       Date:  2001-11       Impact factor: 11.527

9.  Anterior optic neuropathy associated with adalimumab.

Authors:  Burkhard von Jagow; Thomas Kohnen
Journal:  Ophthalmologica       Date:  2008-06-18       Impact factor: 3.250

10.  Interferon-associated retinopathy.

Authors:  D R Guyer; J Tiedeman; L A Yannuzzi; J S Slakter; D Parke; J Kelley; R A Tang; M Marmor; G Abrams; J W Miller
Journal:  Arch Ophthalmol       Date:  1993-03
View more
  2 in total

Review 1.  Inflammatory Disorders of the Skull Base: a Review.

Authors:  Pria Anand; Bart K Chwalisz
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-26       Impact factor: 5.081

Review 2.  Ocular Involvement in Systemic Autoimmune Diseases.

Authors:  Elena Generali; Luca Cantarini; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2015-12       Impact factor: 8.667

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.